Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer…
Cellogen Therapeutics has secured $2 million in funding from NATCO Pharma and is preparing for clinical trials in collaboration…
Entod Pharma appoints Balasubramanian K Pillai as CFO
As CFO, he will oversee financial strategy, budgeting, and risk management, helping Entod strengthen its financial position
Aerogen opens India headquarters to expand access to aerosol drug delivery solutions
Company establishes presence in New Delhi to support respiratory care advancements
FOPE & PharmaState Academy conducts session 17 on gap analysis and implementation plan for…
A structured and well-documented Gap Analysis is essential for identifying deficiencies, strengthening compliance, and ensuring…
Supriya Lifescience expands solar power capacity with 5 MWp facility in Maharashtra
Company strengthens renewable energy commitment with latest solar project
USV launches Xenia: Empagliflozin and its combinations for diabetes care in India
With the loss of exclusivity, Empagliflozin and its combinations are now available at one-fifth the cost, enhancing affordability
Cipla, Formosa sign multi-regional licensing deal for Clobetasol Suspension
This partnership aims to enhance ophthalmic care by providing treatment for post- operative inflammation and pain in patients…
Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset
Shilpa to undertake both development and commercial supply for mAbTree’s novel checkpoint inhibitor
Lupin gains tentative USFDA approval for Amifampridine Tablets
Amifampridine Tablets, 10 mg, are bioequivalent to Firdapse Tablets, 10 mg of Catalyst Pharmaceuticals